Financial Markets
Strides Pharma Science receives USFDA approval for generic version of Theophylline ER Tablets 300 mg and 540 mg
Strides Pharma Science (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. , Singapore, has received approval for the generic version of Theophylline Extended-Release Tablets, 300 mg and 450 mg, from the U
![Strides Pharma Science receives USFDA approval for generic version of Theophylline ER Tablets 300 mg and 540 mg](https://img.easybranches.com/uploads/news/2024/09/strides-pharma-science-receives-usfda-approval-for-generic-version-of-theophylline-er-tablets-300-mg-and-540-mg.jpg)